Page last updated: 2024-08-21

vancomycin and Charcot-Marie-Tooth Disease, Demyelinating, Type 4f

vancomycin has been researched along with Charcot-Marie-Tooth Disease, Demyelinating, Type 4f in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, H; Li, J; Li, Y; Liang, Q; Liu, Y; Liu, Z; Ma, X; Tang, Y; Tong, Y; Wu, H; Yan, Y; Yi, K1

Other Studies

1 other study(ies) available for vancomycin and Charcot-Marie-Tooth Disease, Demyelinating, Type 4f

ArticleYear
A Molecular Switch-Integrated Nanoplatform Enables Photo-Unlocked Antibacterial Drug Delivery for Synergistic Abscess Therapy.
    Advanced healthcare materials, 2023, Volume: 12, Issue:27

    Topics: Abscess; Animals; Anti-Bacterial Agents; Doxorubicin; Hemin; Hereditary Sensory and Motor Neuropathy; Metal Nanoparticles; Mice; Nanoparticles; Silver; Vancomycin

2023